Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions

M Schmidt, FJ Dekker, H Maarsingh - Pharmacological reviews, 2013 - ASPET
Since the discovery nearly 60 years ago, cAMP is envisioned as one of the most universal
and versatile second messengers. The tremendous feature of cAMP to tightly control highly …

cAMP regulation of airway smooth muscle function

CK Billington, OO Ojo, RB Penn, S Ito - Pulmonary pharmacology & …, 2013 - Elsevier
Agonists activating β2-adrenoceptors (β2ARs) on airway smooth muscle (ASM) are the drug
of choice for rescue from acute bronchoconstriction in patients with both asthma and chronic …

Epithelial cells and airway diseases

D Proud, R Leigh - Immunological reviews, 2011 - Wiley Online Library
The airway epithelial cell is the initial cell type impacted both by inhaled environmental
factors, such as pathogens, allergens, and pollutants, and inhaled medications for airway …

The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function

M Grandoch, SS Roscioni… - British journal of …, 2010 - Wiley Online Library
Chronic degenerative inflammatory diseases, such as chronic obstructive pulmonary
disease and Alzheimer's dementia, afflict millions of people around the world, causing death …

[图书][B] Гиперреактивность дыхательных путей

АГ Приходько, ЮМ Перельман, ВП Колосов - 2011 - elibrary.ru
Монография посвящена важной проблеме пульмонологии–роли измененной
реактивности дыхательных путей в формировании, прогрессировании …

Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells

M Kaur, JE Chivers, MA Giembycz, R Newton - Molecular pharmacology, 2008 - ASPET
Addition of an inhaled long-acting β2-adrenoceptor agonist (LABA) to an inhaled
corticosteroid (ICS) is more effective at improving asthma control and reducing …

Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases

R Newton, R Leigh, MA Giembycz - Pharmacology & therapeutics, 2010 - Elsevier
Glucocorticoids are widely used to treat various inflammatory lung diseases. Acting via the
glucocorticoid receptor (GR), they exert clinical effects predominantly by modulating gene …

A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids

MA Giembycz, M Kaur, R Leigh… - British journal of …, 2008 - Wiley Online Library
There is unequivocal evidence that the combination of an inhaled corticosteroid (ICS)—ie
glucocorticoid—and an inhaled long‐acting β2‐adrenoceptor agonist (LABA) is superior to …

Regular treatment with formoterol for chronic asthma: serious adverse events

CJ Cates, MJ Cates… - Cochrane Database of …, 2008 - cochranelibrary.com
Background Epidemiological evidence has suggested a link between beta‐agonists and
increases in asthma mortality. There has been much debate about possible causal links for …

Roles of airway smooth muscle dysfunction in chronic obstructive pulmonary disease

F Yan, H Gao, H Zhao, M Bhatia, Y Zeng - Journal of translational …, 2018 - Springer
The airway smooth muscle (ASM) plays an indispensable role in airway structure and
function. Dysfunction in ASM plays a central role in the pathogenesis of chronic obstructive …